During the past decade, Interlakes Oncology Hematology, PC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 37 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Interlakes Oncology Hematology, PC" #1 sponsor was "SWOG Cancer Research Network" with 24 trials, followed by "National Cancer Institute (NCI)" with 22 trials sponsored, "US Oncology Research" with 7 trials sponsored, "Sanofi" with 4 trials sponsored and "NSABP Foundation Inc" with 4 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Interlakes Oncology Hematology, PC" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Interlakes Oncology Hematology, PC" are "Breast Cancer" (9 trials), "Lymphoma" (6 trials), "Colorectal Cancer" (5 trials), "Lung Cancer" (5 trials) and "Metastatic Breast Cancer" (3 trials). Many other conditions were trialed in "Interlakes Oncology Hematology, PC" in a lesser frequency.

Most popular intervention types in "Interlakes Oncology Hematology, PC" are "Drug" (69 trials), "Biological" (27 trials), "Other" (23 trials), "Procedure" (4 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (16 trials), "Bevacizumab" (10 trials), "oxaliplatin" (8 trials), "Placebo" (7 trials) and "cetuximab" (7 trials). Other intervention names were less common.

The vast majority of trials in "Interlakes Oncology Hematology, PC" are 58 trials for "All" genders, 13 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Interlakes Oncology Hematology, PC". undefined are not yet recruiting, undefined are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 51 completed trials in Interlakes Oncology Hematology, PC, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Interlakes Oncology Hematology, PC, 2 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".